364 related articles for article (PubMed ID: 18540933)
21. 12-month observation of testosterone replacement effectiveness in a general population of men.
Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
[TBL] [Abstract][Full Text] [Related]
22. Testosterone replacement therapy for late-onset hypogonadism.
Cunningham GR
Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.
Spry NA; Kristjanson L; Hooton B; Hayden L; Neerhut G; Gurney H; Corica T; Korbel E; Weinstein S; McCaul K
Eur J Cancer; 2006 May; 42(8):1083-92. PubMed ID: 16632343
[TBL] [Abstract][Full Text] [Related]
24. Recent trends in the treatment of testosterone deficiency syndrome.
Hong BS; Ahn TY
Int J Urol; 2007 Nov; 14(11):981-5. PubMed ID: 17956520
[TBL] [Abstract][Full Text] [Related]
25. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
[TBL] [Abstract][Full Text] [Related]
26. Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus.
Ogbera OA; Sonny C; Olufemi F; Wale A
J Coll Physicians Surg Pak; 2011 Sep; 21(9):517-21. PubMed ID: 21914405
[TBL] [Abstract][Full Text] [Related]
27. Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study.
Li JY; Zhu JC; Dou JT; Bai WJ; Deng SM; Li M; Huang W; Jin H
Aging Male; 2002 Mar; 5(1):47-51. PubMed ID: 12040975
[TBL] [Abstract][Full Text] [Related]
28. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.
Haren M; Chapman I; Coates P; Morley J; Wittert G
Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419
[TBL] [Abstract][Full Text] [Related]
29. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
[TBL] [Abstract][Full Text] [Related]
30. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
31. Patients with testosterone deficit syndrome and depression.
Khera M
Arch Esp Urol; 2013 Sep; 66(7):729-36. PubMed ID: 24047633
[TBL] [Abstract][Full Text] [Related]
32. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Boyanov MA; Boneva Z; Christov VG
Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
[TBL] [Abstract][Full Text] [Related]
33. Testosterone supplementation: what and how to give.
Jockenhövel F
Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
[TBL] [Abstract][Full Text] [Related]
34. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
35. Considerations for the diagnosis and treatment of testosterone deficiency in elderly men.
Kazi M; Geraci SA; Koch CA
Am J Med; 2007 Oct; 120(10):835-40. PubMed ID: 17904450
[TBL] [Abstract][Full Text] [Related]
36. Testosterone deficiency: a common, unrecognized syndrome.
Tostain JL; Blanc F
Nat Clin Pract Urol; 2008 Jul; 5(7):388-96. PubMed ID: 18604225
[TBL] [Abstract][Full Text] [Related]
37. [Testosterone deficiency in elderly men].
Rabijewski M; Zgliczyński W
Pol Merkur Lekarski; 2009 Dec; 27(162):517-23. PubMed ID: 20120721
[TBL] [Abstract][Full Text] [Related]
38. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
39. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
Miner M; Canty DJ; Shabsigh R
Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
[TBL] [Abstract][Full Text] [Related]
40. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men.
Fennell C; Sartorius G; Ly LP; Turner L; Liu PY; Conway AJ; Handelsman DJ
Clin Endocrinol (Oxf); 2010 Jul; 73(1):102-9. PubMed ID: 19891698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
